Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

09. Avril 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1930


	Articles 1 - 20 / 38583

	Research Progress of Nanodelivery Platforms in the Diagnosis and Treatment of Esophageal Cancer. Int J Nanomedicine Sun S, Huang H, Hong H, Lu W, Qiu L, Liu S, Huang S, Ye K, Sun J, Lai G, Liu J. PMID: 41948173 [PubMed - indexed for MEDLINE]
	Gastric synovial sarcoma: the critical role of molecular techniques in diagnosis of an ultra-rare cancer. BMJ Case Rep Elango T, Tolstrup J, Penninga L. PMID: 41946534 [PubMed - indexed for MEDLINE]
	Cancer burden and the contributions of risk factors in China: A systematic analysis for the Global Burden of Disease Study 2021. Chin Med J (Engl) Wu Z, Pang S, Mei Y, Qin C, Jin Y, Lin R. PMID: 41945877 [PubMed - indexed for MEDLINE]
	Next step after endoscopic resection for superficial esophageal squamous cell carcinoma: metastatic risk assessment and management of non-curative resection cases. Clin Endosc Ishihara R. PMID: 41943646 [PubMed]
	Biological Characteristics and Therapeutic Strategies for Resectable Locally Advanced Esophagogastric Junction Cancer: A Comprehensive Update. J Gastric Cancer Fujiwara K, Matsuda S, Morimoto Y, Matsui K, Takeuchi M, Kawakubo H, Kitagawa Y. PMID: 41942354 [PubMed - indexed for MEDLINE]
	Impact of immunochemotherapy administration sequence on overall survival in advanced esophageal and gastric cancers: a propensity score-matched multicenter analysis. Cancer Immunol Immunother Hang J, Wu L, Xiao L, Duan Q, Zhao H, Huang J, Guo J, Huang Y, Zhang D, Cheng G, Dong X, Xue P, Chang J. PMID: 41941004 [PubMed - indexed for MEDLINE]
	Exploratory identification of lycorine as a potential inhibitor of the ACP2/YME1L1 prognostic axis in esophageal squamous cell carcinoma: a multi-omics and computational hypothesis. Mol Genet Genomics Chen F, Zhang J, Xu Y, Wang Y, Cheng J. PMID: 41940976 [PubMed - in process]
	Efficacy of surgery versus definitive chemoradiotherapy following neoadjuvant chemotherapy in T4 esophageal squamous cell carcinoma: a retrospective cohort analysis. Front Oncol Wen S, Wang H, Zhao X, Wen J, Liu X, Yan K, Li S, Song C, Shen W. PMID: 41939449 [PubMed]
	Socioeconomic disparities in treatment and survival of oesophageal and gastric cancer in the Netherlands: a nationwide population-based study. Lancet Reg Health Eur van der Aa DC, Teeken MD, van Laarhoven HWM, Gisbertz SS, Lagarde SM, Mohammad NH, van Rossum PSN, Verhoeven RHA, van Berge Henegouwen MI. PMID: 41939011 [PubMed]
	Megestrol acetate versus dexamethasone to prevent nausea and vomiting in patients with gastric or gastro-oesophageal junction cancer treated with oxaliplatin-based chemotherapy: study protocol of a multicentre, randomised, non-inferiority trial. BMJ Open Luo H, Hu Q, Zeng L, Huang Q, Luo Y, Li T, Chen P, Yi C, Gou H. PMID: 41932699 [PubMed - indexed for MEDLINE]
	Microbiota and esophageal cancer: From dysbiosis to carcinogenesis. Crit Rev Oncol Hematol Rajabnia A, Kazeminejad E, Firouzjaei DA, Javadi K. PMID: 41932533 [PubMed - as supplied by publisher]
	Prospectively Screening for Venous Thromboembolism in Patients with Esophagectomy for Cancer Improves Survival: The Complexity of Simplicity. J Thorac Cardiovasc Surg Jones GD, Raja S, Ahmad U, Raymond DP, Tang A, Rappaport JM, Azari F, Feczko AF, Sudarshan M, Toth AJ, Blackstone EH, Murthy S. PMID: 41932434 [PubMed - as supplied by publisher]
	Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol Yang Y, Liu Z, Li C, Li B, Yu B, Yi J, Zhang X, Chen H, Li H, Tan L, Hua R, Guo X, Yang X, Ma W, Sun Y, Li Z, RAMIE study group. PMID: 41932350 [PubMed - as supplied by publisher]
	Epidemiology of esophageal cancer in Xiamen, China, 2011-2020: trends in incidence, mortality, and survival from a population-based registry study. Cancer Causes Control Zhang H, Chen Y, Lin Y, Chi J, Lan Y, Lou Q, Wu A, Guo Z. PMID: 41931127 [PubMed - indexed for MEDLINE]
	Integrating liquid biopsies and artificial intelligence for early cancer detection: A systematic review and meta-analysis. Eur J Cancer Filis P, Markozannes G, Salgkamis D, Tsiknakis N, Zerdes I, Pagkalidou E, Manou M, Filis N, Papakonstantinou A, Mavroudis D, Matikas A, Tsilidis KK, Foukakis T. PMID: 41930854 [PubMed - as supplied by publisher]
	Prognostic biomarkers related to PANoptosis in esophageal cancer and their immune microenvironment: multi-omics analysis and therapeutic significance. Front Oncol Jie R, Liu Y, Wang T, Wusiman S, Ren H, Tuoheniyazi W, Liu L. PMID: 41930201 [PubMed]
	Residual disease subtyping predicts survival and guides adjuvant immunotherapy in esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy. Front Immunol Wang H, Sun H, Yi S, Jin Y, Lu Y, Zuo R, Yang Y, Dong Z, Guo Y, Pan Z, Jiang Z, Duan X. PMID: 41929523 [PubMed - indexed for MEDLINE]
	Differences in Endoscopy Characteristics Between Providers With the Highest and Lowest Post Endoscopy Upper Gastrointestinal Cancer Rates in England. United European Gastroenterol J Kamran U, Evison F, Morris EJA, Brookes M, Rutter M, Beaton D, McCord M, Adderley NJ, Trudgill N. PMID: 41928574 [PubMed - indexed for MEDLINE]
	Tertiary Lymphoid Structures Predict Efficacy of Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Carcinoma. Ann Clin Lab Sci Rong W, Xu F, Yuan S. PMID: 41927123 [PubMed - indexed for MEDLINE]
	Oxaliplatin-induced peripheral neuropathy in cancer treatment: Mechanisms, risk factors, and management strategies. Adv Clin Exp Med Pigo, Banach M, Walkowiak PS, Zygulska A. PMID: 41926777 [PubMed - as supplied by publisher]

Articles 1 - 20 / 38583

Page 1 de 1930



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité